Clinical Trials
20 trialsNCT00068003 2026-05-01
Harvesting Cells for Experimental Cancer Treatments
National Institutes of Health Clinical Center (CC)
Enrolling by invitation
NCT02333604 2026-04-23
CER
Cancer Support Community, Research and Training Institute, Philadelphia
Recruiting
NCT06349642 2026-03-12
ELEPHAS-04
Mayo Clinic
Recruiting
NCT05863052 2026-02-10
Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population
University of Oklahoma
Active not recruiting
NCT04911998 2026-01-12
TavieSkin
Pierre Fabre Medicament
Completed
NCT06075524 2025-12-26
Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types
Mayo Clinic
Recruiting
NCT03452774 2025-10-28
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
Recruiting
NCT03728842 2025-10-27
Spontaneous Regression in Metastatic Melanoma and Renal Cell Carcinoma
Indiana University
Active not recruiting
NCT03798977 2024-02-06
ERMELATHER
Centre Hospitalier Universitaire de Nice
Completed
NCT05845632 2023-08-16
Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell Carcinoma
Maastricht University Medical Center
Unknown
NCT05061940 2022-12-06
This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.
Repertoire Immune Medicines
Terminated
NCT05380336 2022-06-01
IMEPOCA
Nantes University Hospital
Completed
NCT02780089 2022-05-23
Study in Patients With Unresectable And Metastatic Melanoma: The Optimize Study
Bristol-Myers Squibb
Completed
NCT03896958 2020-12-04
PIONEER
SpeciCare
Unknown
NCT00406120 2018-06-26
Validation of a Molecular Prognostic Test for Eye Melanoma
Washington University School of Medicine
Withdrawn
NCT01312506 2016-07-27
Collection of Cerebrospinal Fluid and Tumor Tissue in Subjects With Metastatic Melanoma and Controls
University of Pittsburgh
Withdrawn
NCT00184275 2014-03-07
Characterization of Brain Metastases
Norwegian University of Science and Technology
Completed
NCT00348088 2012-12-13
Melanoma Biomarker Study
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Completed
NCT00184288 2011-11-02
Proton MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response.
Norwegian University of Science and Technology
Withdrawn
NCT00406900 2006-12-06
Melanoma Inhibitory Activity (MIA): A Serological Marker for Metastatic Uveal Melanoma
Ludwig-Maximilians - University of Munich
Unknown